vs
CORCEPT THERAPEUTICS INC(CORT)与南玻集团(CSGS)财务数据对比。点击上方公司名可切换其他公司
南玻集团的季度营收约是CORCEPT THERAPEUTICS INC的1.6倍($323.1M vs $202.1M),CORCEPT THERAPEUTICS INC净利率更高(12.0% vs 2.2%,领先9.8%),CORCEPT THERAPEUTICS INC同比增速更快(11.1% vs 2.0%),南玻集团自由现金流更多($55.8M vs $38.4M),过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高(17.3% vs 4.6%)
Corcept Therapeutics是一家制药企业,专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究,致力于开发可缓解相关症状的新型化合物,管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
中国南玻集团股份有限公司是中国规模最大的建筑玻璃生产商,业务涵盖浮法玻璃、建筑玻璃、显示玻璃、汽车玻璃、镀膜玻璃、镜子、彩滤玻璃、太阳能玻璃及节能玻璃等各类玻璃产品的研发、生产与销售,产品广泛应用于建筑、消费电子、新能源汽车、光伏等多个领域。
CORT vs CSGS — 直观对比
营收规模更大
CSGS
是对方的1.6倍
$202.1M
营收增速更快
CORT
高出9.1%
2.0%
净利率更高
CORT
高出9.8%
2.2%
自由现金流更多
CSGS
多$17.4M
$38.4M
两年增速更快
CORT
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $202.1M | $323.1M |
| 净利润 | $24.3M | $7.0M |
| 毛利率 | 98.7% | 50.0% |
| 营业利润率 | 2.2% | 9.0% |
| 净利率 | 12.0% | 2.2% |
| 营收同比 | 11.1% | 2.0% |
| 净利润同比 | -21.0% | -79.7% |
| 每股收益(稀释后) | $0.20 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CORT
CSGS
| Q4 25 | $202.1M | $323.1M | ||
| Q3 25 | $207.6M | $303.6M | ||
| Q2 25 | $194.4M | $297.1M | ||
| Q1 25 | $157.2M | $299.5M | ||
| Q4 24 | $181.9M | $316.7M | ||
| Q3 24 | $182.5M | $295.1M | ||
| Q2 24 | $163.8M | $290.3M | ||
| Q1 24 | $146.8M | $295.1M |
净利润
CORT
CSGS
| Q4 25 | $24.3M | $7.0M | ||
| Q3 25 | $19.7M | $20.5M | ||
| Q2 25 | $35.1M | $12.3M | ||
| Q1 25 | $20.5M | $16.1M | ||
| Q4 24 | $30.7M | $34.5M | ||
| Q3 24 | $47.2M | $19.1M | ||
| Q2 24 | $35.5M | $13.8M | ||
| Q1 24 | $27.8M | $19.5M |
毛利率
CORT
CSGS
| Q4 25 | 98.7% | 50.0% | ||
| Q3 25 | 97.8% | 48.1% | ||
| Q2 25 | 98.2% | 49.5% | ||
| Q1 25 | 98.5% | 48.4% | ||
| Q4 24 | 98.4% | 51.3% | ||
| Q3 24 | 98.4% | 49.4% | ||
| Q2 24 | 98.5% | 47.3% | ||
| Q1 24 | 98.3% | 46.5% |
营业利润率
CORT
CSGS
| Q4 25 | 2.2% | 9.0% | ||
| Q3 25 | 4.9% | 10.0% | ||
| Q2 25 | 13.7% | 10.0% | ||
| Q1 25 | 2.2% | 9.8% | ||
| Q4 24 | 13.9% | 13.4% | ||
| Q3 24 | 25.5% | 10.8% | ||
| Q2 24 | 21.7% | 8.8% | ||
| Q1 24 | 20.1% | 10.8% |
净利率
CORT
CSGS
| Q4 25 | 12.0% | 2.2% | ||
| Q3 25 | 9.5% | 6.7% | ||
| Q2 25 | 18.1% | 4.1% | ||
| Q1 25 | 13.1% | 5.4% | ||
| Q4 24 | 16.9% | 10.9% | ||
| Q3 24 | 25.9% | 6.5% | ||
| Q2 24 | 21.7% | 4.8% | ||
| Q1 24 | 18.9% | 6.6% |
每股收益(稀释后)
CORT
CSGS
| Q4 25 | $0.20 | $0.24 | ||
| Q3 25 | $0.16 | $0.73 | ||
| Q2 25 | $0.29 | $0.44 | ||
| Q1 25 | $0.17 | $0.57 | ||
| Q4 24 | $0.25 | $1.20 | ||
| Q3 24 | $0.41 | $0.67 | ||
| Q2 24 | $0.32 | $0.48 | ||
| Q1 24 | $0.25 | $0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $180.0M |
| 总债务越低越好 | — | $539.5M |
| 股东权益账面价值 | $647.8M | $283.7M |
| 总资产 | $836.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 1.90× |
8季度趋势,按日历期对齐
现金及短期投资
CORT
CSGS
| Q4 25 | $372.2M | $180.0M | ||
| Q3 25 | $421.7M | $158.4M | ||
| Q2 25 | $342.2M | $145.9M | ||
| Q1 25 | $322.8M | $136.0M | ||
| Q4 24 | $383.3M | $161.8M | ||
| Q3 24 | $380.3M | $118.4M | ||
| Q2 24 | $473.2M | $110.4M | ||
| Q1 24 | $410.8M | $120.8M |
总债务
CORT
CSGS
| Q4 25 | — | $539.5M | ||
| Q3 25 | — | $538.6M | ||
| Q2 25 | — | $537.8M | ||
| Q1 25 | — | $537.6M | ||
| Q4 24 | — | $538.5M | ||
| Q3 24 | — | $539.5M | ||
| Q2 24 | — | $540.5M | ||
| Q1 24 | — | $541.5M |
股东权益
CORT
CSGS
| Q4 25 | $647.8M | $283.7M | ||
| Q3 25 | $631.9M | $289.5M | ||
| Q2 25 | $635.8M | $290.7M | ||
| Q1 25 | $683.3M | $283.1M | ||
| Q4 24 | $679.6M | $282.6M | ||
| Q3 24 | $638.8M | $288.4M | ||
| Q2 24 | $596.2M | $273.3M | ||
| Q1 24 | $547.9M | $269.3M |
总资产
CORT
CSGS
| Q4 25 | $836.7M | $1.5B | ||
| Q3 25 | $823.6M | $1.5B | ||
| Q2 25 | $801.7M | $1.4B | ||
| Q1 25 | $846.5M | $1.4B | ||
| Q4 24 | $840.6M | $1.5B | ||
| Q3 24 | $784.3M | $1.4B | ||
| Q2 24 | $714.6M | $1.4B | ||
| Q1 24 | $655.9M | $1.3B |
负债/权益比
CORT
CSGS
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.86× | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 1.91× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 2.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $38.4M | $59.2M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $55.8M |
| 自由现金流率自由现金流/营收 | 19.0% | 17.3% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.58× | 8.46× |
| 过去12个月自由现金流最近4个季度 | — | $141.4M |
8季度趋势,按日历期对齐
经营现金流
CORT
CSGS
| Q4 25 | $38.4M | $59.2M | ||
| Q3 25 | $54.5M | $47.9M | ||
| Q2 25 | $43.9M | $37.3M | ||
| Q1 25 | $5.1M | $11.5M | ||
| Q4 24 | $59.3M | $82.5M | ||
| Q3 24 | $73.8M | $39.5M | ||
| Q2 24 | $41.2M | $43.1M | ||
| Q1 24 | $23.8M | $-29.4M |
自由现金流
CORT
CSGS
| Q4 25 | $38.4M | $55.8M | ||
| Q3 25 | — | $43.9M | ||
| Q2 25 | $43.9M | $34.6M | ||
| Q1 25 | $5.0M | $7.1M | ||
| Q4 24 | $59.2M | $76.6M | ||
| Q3 24 | $72.2M | $32.0M | ||
| Q2 24 | $40.8M | $38.8M | ||
| Q1 24 | — | $-34.1M |
自由现金流率
CORT
CSGS
| Q4 25 | 19.0% | 17.3% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | 22.6% | 11.6% | ||
| Q1 25 | 3.2% | 2.4% | ||
| Q4 24 | 32.5% | 24.2% | ||
| Q3 24 | 39.5% | 10.8% | ||
| Q2 24 | 24.9% | 13.4% | ||
| Q1 24 | — | -11.6% |
资本支出强度
CORT
CSGS
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.1% | 1.9% | ||
| Q3 24 | 0.9% | 2.5% | ||
| Q2 24 | 0.3% | 1.5% | ||
| Q1 24 | 0.0% | 1.6% |
现金转化率
CORT
CSGS
| Q4 25 | 1.58× | 8.46× | ||
| Q3 25 | 2.77× | 2.34× | ||
| Q2 25 | 1.25× | 3.04× | ||
| Q1 25 | 0.25× | 0.71× | ||
| Q4 24 | 1.93× | 2.39× | ||
| Q3 24 | 1.56× | 2.07× | ||
| Q2 24 | 1.16× | 3.12× | ||
| Q1 24 | 0.86× | -1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |